scispace - formally typeset
T

Tim S. Nawrot

Researcher at University of Hasselt

Publications -  526
Citations -  21558

Tim S. Nawrot is an academic researcher from University of Hasselt. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 66, co-authored 447 publications receiving 16706 citations. Previous affiliations of Tim S. Nawrot include University of Vermont & Katholieke Universiteit Leuven.

Papers
More filters
Journal ArticleDOI

Cadmium stress: an oxidative challenge

TL;DR: The current review gives an overview on Cd-induced ROS production and anti-oxidative defense in organisms under different Cd regimes and the C d-induced oxidative challenge is discussed with a focus on damage and signaling as downstream responses.
Journal ArticleDOI

Environmental exposure to cadmium and risk of cancer: a prospective population-based study

TL;DR: Overall cancer risk was significantly associated with a doubling of 24-h cadmium excretion, and historical pollution from non-ferrous smelters continues to present a serious health hazard, necessitating targeted preventive measures.
Journal ArticleDOI

Public health importance of triggers of myocardial infarction: a comparative risk assessment

TL;DR: Air pollution is an important trigger of myocardial infarction, it is of similar magnitude as other well accepted triggers such as physical exertion, alcohol, and coffee and shows that ever-present small risks might have considerable public health relevance.
Journal ArticleDOI

Gender and telomere length : systematic review and meta-analysis

Michael P. Gardner, +53 more
TL;DR: Telomere length is longer in females than males, although this difference was not universally found in studies that did not use Southern blot methods, and further research on explanations for the methodological differences is required.
Journal ArticleDOI

Prevalence, Persistence, and Clinical Significance of Masked Hypertension in Youth

TL;DR: In children and adolescents, masked hypertension is a precursor of sustained hypertension and left ventricular hypertrophy and, once it becomes persistent, is an indication for blood pressure-lowering treatment.